Tech Company Financing Transactions

Tavros Therapeutics Funding Round

KdT Ventures, Piedmont Investment Advisors and Alexandria Venture Investments joined a $7.5 million Seed funding round for Tavros Therapeutics. The round was announced by the company on 9/27/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

701 West Main St. 200
Durham, NC 27701
USA

Phone

Undisclosed

Website

www.tavrostx.com

Email Address

[email protected]

Overview

Tavros Therapeutics is discovering and developing first-in-class, targeted cancer therapies. We are a science-first company and believe the future of cancer therapy lies in identifying how to best position drugs in the clinic through a deep understanding of drug biology.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eoin McDonnell

        

Chief Financial Officer

Nikki Heron

        

Co-Founder

Kris Wood

        

VP - Bus. Development

Greg Mossinghoff

        

Browse more venture capital transactions:

Prev: 9/27/2022: Tray.io venture capital transaction
Next: 9/27/2022: Employee Cycle venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary